Vaccine Access Test 2.0

Tracking Actions to Improve Global Access

The COVID-19 pandemic doesn’t end with a vaccine. It ends when everyone can get it.

The evidence couldn’t be more clear: as long the virus remains unchecked anywhere on the planet, it will continue to mutate, breach borders, and wreak havoc on the global economy.

The first version of the Vaccine Access Test – launched in September 2020 – measured how well countries were supporting the development of COVID-19 vaccines and setting the stage for equitable distribution. By the end of 2020, it was clear that the new year would bring a new phase of the COVID-19 response and that the Vaccine Access Test would also need to evolve to better meet this moment.

The Vaccine Access Test 2.0 grades how well world leaders are improving access to safe and effective COVID-19 vaccines globally based on the following metrics:

Global Cooperation

  • Financially supports the Access to COVID-19 Tools Accelerator (ACT-A)
  • Joins COVAX
  • Uses political capital to advance global access
  • Leads by example by enforcing clear national allocation guidelines that prioritize the most vulnerable

Increasing Supply for All

  • Shares doses, preferably with COVAX
  • Supports temporarily loosening trade restrictions
  • Incentivizes participation in the COVID-19 Technology Access Pool (C-TAP)
  • Prohibits export bans

We have scored the G20 and the companies striking deals for promising vaccine candidates. Here’s how they stack up:



(All downloads are PDF documents.)

  • Summary & Methodology
    • Vaccine Access Test One-page Global Summary - April 2021 EN
    • Vaccine Access Test One-page Global Summary - March 2021 EN
    • Vaccine Access Test One-page Global Summary - January 2021 EN | DE | FR
    • Vaccine Access Test One-page Global Summary - November 2020 EN | DE | FR
    • Vaccine Access Test One-page Global Summary - October 2020 EN | DE | FR
    • Vaccine Access Test One-page Global Summary - September 2020 EN | DE | FR
    • Vaccine Access Test Methodology 2.0 EN
  • Countries & Regions
    • Vaccine Access Test Score Summary: Italy IT
    • Vaccine Access Test Score Summary: Netherlands NL

Learn more

Each score is influenced by multiple factors, but commonalities exist across actors in each category:

  • Those who are impeding equity are going it alone, failing to work across borders and to share information.
  • Those with room for improvement are taking some welcome actions collectively to speed the delivery of vaccines globally, but lack consistency on equity across policies and deals.
  • While no one has reached the pinnacle of advancing equity, this must change as more actions are taken. ONE will release updated scores the first week of every month to see who is rising to the challenge to end the pandemic.

The Vaccine Access Test is intended to start conversations and even debates around how to end this pandemic, and lead to concrete actions that move us collectively in the right direction.

Because none of us are safe until all of us are safe.